POLISCOPE
Topic18 documents tagged

Clinical Trials

What This Page Covers

This page collects the 18 public records POLISCOPE has tagged with “Clinical Trials”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Biotechnology, and Medical Research.

Active Bills

Federal BillFEDERALApr 6, 2026Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026This bill extends federal funding and research programs for Amyotrophic Lateral Sclerosis (ALS) through 2031. It also introduces new requirements for clinical trial data sharing and mandates a comprehState BillVERMONTFeb 3, 2026Vermont Bill H.859 Establishes Psychedelic Therapy Advisory Board and Mandates Ibogaine Clinical TrialsFederal BillFEDERALJun 26, 2025House bill excludes clinical trial compensation from federal taxable incomeFederal BillFEDERALMay 20, 2025Clinical Trial Modernization Act introduced to reform medical research protocolsFederal BillFEDERALApr 9, 2025The BRAIN Act (Bolstering Research And Innovation Now Act)Federal BillFEDERALDec 17, 2024Childhood Cancer Clinical Trials Act

Recent Activity

  1. Mon, Sep 141 item
    1. 858 Therapeutics studies potential breast and ovarian cancer treatmentsClinical-stage drug developer 858 Therapeutics is advancing clinical studies for its lead drug candidate, ETX-19477, targeting breast and ovarian cancer subtypes in patients with BRCA gene mutations.San Diego County
  2. Mon, Aug 311 item
    1. Revelation Biosciences evaluates Gemini drug candidate for kidney disease and infection treatmentsRevelation Biosciences is testing its proprietary drug candidate, Gemini, to treat acute kidney injury, chronic kidney disease, post-surgical infections, and hyperinflammation from severe burns. The cSan Diego County
  3. Mon, Aug 171 item
    1. BlossomHill Therapeutics raises $150 million in Nasdaq initial public offeringBlossomHill Therapeutics launched its initial public offering on the Nasdaq stock exchange on August 7, raising $150 million. The company plans to use the capital to support late-stage clinical studieSan Diego County
  4. Tue, Aug 41 item
    1. Erasca, Inc. to release clinical trial data for cancer drug candidates this yearSan Diego-based oncology company Erasca, Inc. plans to publish safety and efficacy results for two drug candidates targeting non-small cell lung cancer later this year. The company is currently in theSan Diego County
  5. Wed, Jul 291 item
    1. Arcturus Therapeutics Partners with Thermo Fisher to Produce New Cystic Fibrosis DrugArcturus Therapeutics has entered a manufacturing agreement with Thermo Fisher Scientific to produce its experimental mRNA-based cystic fibrosis treatment, ARCT-032. The drug is currently in Phase 2 cSan Diego County
  6. Thu, Jul 21 item
    1. Local Clinical Trial Helps College Athlete Return to BaseballA 24-year-old college athlete diagnosed with a chronic kidney disease was able to return to his sport after participating in a clinical trial at Kaiser Permanente Southern California. The trial providLos Angeles County

Finance Signals

No finance signals found for this topic in the available records yet.

Trace money trail →

Open the Money page to search by entity, donor, or PAC.

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01San Diegolocation3 mentions
  2. 02Food and Drug Administrationorganization2 mentions
  3. 03Jubilee McGillperson1 mentions
  4. 04BLSMother1 mentions
  5. 05858 Therapeuticsorganization1 mentions
  6. 06Nasdaq: ERASother1 mentions
  7. 07Brian Fitzpatrickperson1 mentions
  8. 08Lori Trahanperson1 mentions
  9. 09Kaiser Permanente Southern Californiaorganization1 mentions
  10. 10Vermont Association for Mental Health and Addiction Recoveryorganization1 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsAccelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, Vermont Bill H.859 Establishes Psychedelic Therapy Advisory Board and Mandates Ibogaine Clinical Trials, House bill excludes clinical trial compensation from federal taxable income (+3 more)
  • Topic to peopleJubilee McGill, Brian Fitzpatrick, Lori Trahan
  • Topic to orgsFood and Drug Administration, 858 Therapeutics, Kaiser Permanente Southern California (+1 more)
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. Sep 14, 2026News858 Therapeutics studies potential breast and ovarian cancer treatments
  2. Aug 31, 2026NewsRevelation Biosciences evaluates Gemini drug candidate for kidney disease and infection treatments
  3. Aug 17, 2026NewsBlossomHill Therapeutics raises $150 million in Nasdaq initial public offering
  4. Aug 4, 2026NewsErasca, Inc. to release clinical trial data for cancer drug candidates this year
  5. Jul 29, 2026NewsArcturus Therapeutics Partners with Thermo Fisher to Produce New Cystic Fibrosis Drug
  6. Jul 2, 2026NewsLocal Clinical Trial Helps College Athlete Return to Baseball
  7. May 15, 2026congressional recordCongressional Tribute to Urbana Councilwoman Chaundra Bishop
  8. Apr 6, 2026Federal BillAccelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
  9. Feb 3, 2026State BillVermont Bill H.859 Establishes Psychedelic Therapy Advisory Board and Mandates Ibogaine Clinical Trials
  10. Jun 26, 2025Federal BillHouse bill excludes clinical trial compensation from federal taxable income

Showing 10 of 18 source records.